Shawn Iadonato

CEO, Kineta

Shawn Iadonato, Ph.D., serves as Kineta's chief executive officer. He is a co-founder of Kineta and previously served as chief scientific officer. Under his leadership as CSO, the Kineta pipeline expanded to include the AviiD Screening Platform and five novel drug and vaccine programs with a focus on autoimmune diseases, antivirals, and chronic pain.

Prior to founding Kineta, Shawn co-founded and served as CSO of Illumigen Biosciences Inc. At Illumigen Biosciences, he pioneered its patented drug discovery platform, which relied upon recruitment and screening of healthy populations and elucidation of their shared "wellness" genes. Shawn also led the successful discovery and preclinical development of Illumigen's anti-hepatitis C drug, which ultimately led to the sale of the company in December 2007 to Cubist Pharmaceuticals (now part of Merck & Co.).

Before Illumigen, Shawn managed the Human Genome Center at the University of Washington. He is co-inventor on more than 35 US patents or patent applications. He is principal investigator or co-investigator on numerous ongoing government grants and contracts.

Shawn received a Ph.D. in Genetics from the University of Washington and is a graduate of the University of Pennsylvania.


Share this: Share on Facebook Tweet about this on Twitter Share on Google+ Share on LinkedIn Email this to someone

News for: Shawn Iadonato

Speaker at FiRe 2016

News Headlines  (10 of 11)
Kineta Invited to Participate at October 2019 Investor Conferences
Posted on 6 Oct 2019 at 5:00pm

Kineta Invited to Participate at the H.C. Wainwright 21st Annual Global Inves...
Posted on 28 Aug 2019 at 5:45am

Biotech startup Kineta inks cancer deal with Pfizer worth up to $505M
Posted on 17 Dec 2018 at 5:01am

Kineta Invited to Participate at Solebury Trout's 9th Annual CEO Roundtable C...
Posted on 12 Aug 2019 at 5:54am

Kineta Raises $1.8M in Funding
Posted on 6 Aug 2019 at 2:20pm

Innovators: Shawn Iadonato is preparing Kineta to go public this year
Posted on 19 Feb 2019 at 5:02am

Local drug makers race to develop non-opioid pain medication
Posted on 12 Jun 2019 at 11:27am

Innovators of the Year: Kineta is 'decorating tumor cells' to make them easie...
Posted on 23 May 2019 at 2:05pm

Kineta Secures NIAID Grant Worth Up to $5.8M to Evaluate LHF-535 in Arenaviruses
Posted on 14 Jul 2019 at 5:00pm

Kineta Invited to Participate at the H.C. Wainwright 21st Annual Global Inves...
Posted on 28 Aug 2019 at 5:41am



News feeds courtesy of:

FiRe 2016 Media


Bleeding-Edge Medicine: Today's Discoveries, Tomorrow's Practice



Share this video: Share on Facebook Tweet about this on Twitter Share on Google+ Share on LinkedIn Email this to someone

To contact Shawn Iadonato, fill out the form below.

iNews Mailroom (All fields required)
To:
From:
Your Email:
Subject:

Message: